Webinar: Clinical Trials in Latin America - Translating for Success

Moravia Worldwide is pleased to announce a free live webinar titled "Clinical Trials in Latin America – Translating for Success". This webinar will outline the regulatory environment governing clinical trials in Latin America, the key considerations when deciding in what emerging market to conduct clinical trials, and the necessary linguistic and cultural considerations, with a focus on language translation needs and requirements.

Presented by Richard Chin, Moravia's Life Sciences Practice Lead, the webinar will provide practical, actionable insights for life sciences companies conducting clinical trials in Latin America, or those considering doing so, helping them to understand what it takes to succeed, and how to ensure language compliance.

The webinar will be held on Wednesday, May 26, 2010 at 11:00 EDT (8:00 PDT, 17:00 CET). Space is limited. Reserve your webinar seat now. After registering you will receive a confirmation email containing information about how to join the webinar.

Moravia’s dedicated Life Sciences Practice helps life sciences and healthcare companies reach global markets and satisfy local regulatory requirements, by providing translation and localization services that support their efforts from clinical trials through product launch.

Who Should Attend

The webinar is intended for life sciences client organizations - pharmaceutical or biotech companies, CROs, patient recruitment companies and medical device manufacturers, and staff typically in positions such as:

• Clinical Operations
• Patient Recruitment Managers
• Medical Writers
• Regulatory Affairs Managers
• Regulatory Operations or Strategic Planning Managers
• Labeling and Packaging Managers
• Translation or Localization Managers
• Other staff involved in clinical trials or translations

Facts and Figures – Where Latin America Fits In

• By 2012, more than 65% of FDA-regulated clinical trials for leading pharmaceutical companies will be conducted outside of the United States. Where to conduct clinical trials can depend on many criteria, including the location of corporate global facilities, costs, regulations and future product launch plans.
• More and more, emerging market regions are being considered because they offer significant market potential without compromising the quality of the trials.
• Of the total pharmaceutical market in Latin America, Mexico, Brazil and Argentina (accounting for 37.4%, 28.4%, and 15.3% of the total pharmaceutical market, respectively) have seen the most clinical trials. These countries have more advanced regulatory guidelines and streamlined trial approval processes.